Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma [Phase 2]
Phase 2 trial of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with unresectable stage III–IV melanoma was terminated, with …
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Quality of Life and Surgical Late Effects of Melanoma Treatment
Clinical trial evaluating quality of life and surgical late effects after melanoma treatment has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma [Phase 1]
Phase 1 safety study of the GVAX melanoma vaccine with or without cyclophosphamide for patients with surgically resected melanoma has comple…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting
A completed clinical trial assessing the prevalence of pain and associated risk factors among outpatient patients with sarcoma or melanoma.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma [Phase 2]
Phase 2 trial of a NY-ESO-1–targeted T cell receptor therapy in NY-ESO-1 expressing metastatic melanoma was terminated, with results posted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma [Phase 3]
Phase 3 trial results for high-dose interferon alfa-2b in stage II or stage III melanoma have been posted.
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients [Phase 2]
Phase 2 trial investigating platinum-based chemotherapy to improve dendritic cell vaccine efficacy in melanoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma [Phase 1]
This phase 1 trial evaluated the combination of lenalidomide and dacarbazine in patients with metastatic melanoma and is now completed.
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2 [Phase 2]
Phase 2 study of irradiated donor lymphocyte infusion plus high-dose interleukin-2 for metastatic melanoma and renal cell carcinoma was term…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis
A completed clinical trial evaluating the sensitivity and specificity of a non-invasive imaging method for diagnosing melanoma.
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Clinical trial evaluating a biological therapy's effect on biomarkers in untreated Hepatitis C, metastatic melanoma, and Crohn's disease was…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Safety and Pharmacodynamic Study of a New Formulation, AGI - 101H Vaccine in the Treatment of Advanced Melanoma [Phase 1, Phase 2]
A safety and pharmacodynamic study of the AGI-101H vaccine for advanced melanoma has been terminated after Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies [Phase 1]
Phase 1 study of nivolumab (BMS-936558) in advanced or recurrent malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients [Phase 1]
This document describes a Phase 1 tolerability and pharmacokinetics study of SHR6390 in patients with advanced melanoma. The sponsor is Jian…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI [EARLY_Phase 1]
Update on an early-phase trial evaluating the safety and immune response of MAGE-A3 ASCI in patients with resected stage IIB-IV melanoma; th…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma [Phase 2]
Phase 2 trial update of a vaccine therapy plus interleukin-2, with or without interferon alfa-2b, in patients with Stage III melanoma; the s…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)
This clinical trial update reports on how different excision margins affect survival and recurrence in patients with thick melanoma (>2 mm).
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples
A completed clinical trial compared in-house methods against the Cobas BRAF V600 mutation assay for detecting BRAF V600 mutations in melanom…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma [Phase 2]
Phase 2 trial assessing bevacizumab with or without interferon alfa-2b in patients with metastatic melanoma has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma [Phase 2]
Phase 2 open-label trial of lenvatinib in previously treated patients with unresectable stage III or stage IV melanoma completed; results po…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Post-Approval Study of MelaFind
Post-approval study of the melanoma diagnostic device MelaFind has been terminated (status: TERMINATED).
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma [Phase 2]
Phase 2 clinical trial update for FR901228 in unresectable stage III or stage IV malignant melanoma (melanoma) has been terminated with resu…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma [Phase 3]
Phase 3 trial comparing nivolumab to dacarbazine in untreated unresectable or metastatic melanoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma [Phase 1]
Phase 1 trial evaluating ADI-PEG 20 plus cisplatin in metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial evaluating paclitaxel albumin-stabilized nanoparticle formulation (nab-paclitaxel) for metastatic intraocular melanom…